BCBA/BMY (BCBA/BMY)

Buenos Aires Stock Exchange: BCBA/BMY · ARS

ARS 33,920

-481.62 (-1.4%)· Recorded snapshot

Market cap	193.4T
Revenue (ttm)	72.9T
Net income (ttm)	13.8T
EPS (ttm)	ARS 2,329
P/E (trailing)	14.6x
P/E (forward)	10.1x
Dividend	ARS 893 (2.63%)
Volume	618

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 72.9T
Net income (ttm): 13.8T
EPS (ttm): ARS 2,329
P/E (trailing): 14.6x
P/E (forward): 10.1x
Market cap: 193.4T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.1

P25 n/aP50 n/aP75 n/a

Trailing P/E14.6

P25 n/aP50 n/aP75 n/a

ROE46.6

P25 n/aP50 n/aP75 n/a

ROIC21.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/BMY indicators

Market & fundamental data

Available fields

248

Groups with data

Currency

USD

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-29
Employees	32,500
Employees change	0
Employees growth	0%
Enterprise value	ARS 245.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1887
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112877
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2020-10-22
Last stock split type	Forward
Market cap	ARS 193.4T
Next earnings date	2026-10-29
Price	ARS 33,920.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/BMY
Website	https://www.bms.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	38.47x
Average P/E ratio (3Y)	16.21x
Average P/E ratio (5Y)	18.92x
Earnings yield	6.87%
EV/Earnings	17.82x
EV/EBIT	10.08x
EV/EBITDA	8.19x
EV/FCF	14.46x
EV/Sales	3.24x
FCF / EV yield	6.92%
FCF yield	8.76%
Forward P/E	10.09x
Graham number	17740.19288
Graham upside	-47.7%
Lynch fair value	ARS 12,642.44
Lynch upside	-62.73%
P/(FCF - SBC) ratio	11.99x
P/(OCF - SBC) ratio	10.67x
P/B ratio	5.85x
P/E ratio	14.56x
P/FCF ratio	11.41x
P/OCF ratio	10.21x
P/S ratio	2.65x
Price/EBITDA ratio	6.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	31.79%
EBITDA margin	38.49%
Effective tax rate	22.12%
FCF margin	22.4%
Gross margin	71.66%
Operating margin	31.79%
Pretax margin	24.21%
Profit margin	18.87%
Profit per employee	ARS 423.1M
Profitable quarters	9
Profitable years	1
Revenue per employee	ARS 2.2B
ROA	10.72%
ROA (5Y)	6.51%
ROCE	22.67%
ROE	46.6%
ROE (5Y)	13.18%
ROIC	21.68%
ROIC (5Y)	14.63%
SBC / revenue	1.12%
Tax / revenue	5.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	82.74%
EPS growth (Q)	153.13%
EPS growth (QoQ)	23.66%
EPS growth 10Y	10.27%
EPS growth 3Y	6.51%
EPS growth quarters	4
EPS growth years	1
FCF growth	-21.53%
FCF growth (Q)	-13.16%
FCF growth (QoQ)	307.93%
FCF growth 3Y	2.19%
FCF growth 5Y	-0.43%
Gross profit growth	-0.04%
Gross profit growth (Q)	3.92%
Gross profit growth 3Y	0.16%
Gross profit growth 5Y	-0.04%
Net income growth	83.84%
Net income growth (Q)	153.21%
Net income growth (QoQ)	23.91%
Net income growth 3Y	5.24%
Net income growth quarters	4
Net income growth years	1
OCF growth	-19.62%
OCF growth (Q)	-13.38%
OCF growth (QoQ)	207.34%
OCF growth 10Y	25.24%
OCF growth 3Y	2.56%
OCF growth 5Y	0.44%
Operating income growth	23.89%
Operating income growth (Q)	8.06%
Operating income growth 3Y	21.58%
Operating income growth 5Y	13.64%
Revenue growth	3.11%
Revenue growth (Q)	5.74%
Revenue growth (QoQ)	12.92%
Revenue growth 10Y	10.81%
Revenue growth 3Y	2.87%
Revenue growth 5Y	2.08%
Revenue growth quarters	5
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -2T
Depreciation and amortization	ARS 5.1T
EBIT	ARS 23.2T
EBITDA	ARS 28T
EPS	ARS 2,329.27
Financing cash flow	ARS -17.3T
Free cash flow	ARS 16.9T
Free cash flow minus SBC	ARS 16.1T
Gross profit	ARS 52.2T
Income taxes	ARS 3.9T
Investing cash flow	ARS -7.3T
Net borrowing	ARS -10T
Net cash flow	ARS -5.8T
Net income	ARS 13.8T
Operating cash flow minus SBC	ARS 18.1T
Operating income	ARS 23.2T
Revenue	ARS 72.9T
Stock-based compensation	ARS 819.3B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.59
Book value per share	ARS 16,184.82
Debt / EBITDA	2.34
Debt / equity	2.02
Debt / FCF	3.94
Goodwill	ARS 33.4T
Interest coverage	9.07
Long-term assets	ARS 85.9T
Long-term liabilities	ARS 68.1T
Net cash (debt)	ARS -49.8T
Net cash / market cap	-25.73%
Net debt / EBITDA	1.77
Net debt / equity	1.5
Net debt / FCF	2.94
Piotroski F-Score	7
Property, plant and equipment	ARS 14.3T
Shareholders' equity	ARS 33.1T
Tangible book value	ARS -24.9T
Tangible book value per share	ARS -12,188.47
Total assets	ARS 129.8T
Total cash	ARS 16.4T
Total debt	ARS 66.7T
Total liabilities	ARS 96.8T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	ARS 44T
Current liabilities	ARS 28.7T
Current ratio	1.53
Inventory turnover	5.09
Net working capital	ARS 128.9B
Quick ratio	1.29
Working capital	ARS 14.7T
Working capital turnover	9,333.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.47%
Dividend growth	43.6%
Dividend growth (10Y)	54.58%
Dividend growth (3Y)	95.24%
Dividend growth (5Y)	88.76%
Dividend growth years	8
Dividend payment date	2026-11-02
Dividend payment years	22
Dividend payout frequency	Quarterly
Dividend per share	ARS 893.38
Dividend yield	2.63%
Ex-dividend date	2026-10-02
Last dividend	ARS 320.25
Payout ratio	54.89%
Shareholder yield	2.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 31,159.07
1D price change	-1.4%
1M price change	0.24%
1M total return	1.21%
1W price change	6.8%
1W total return	6.8%
1Y price change	48.58%
1Y return CAGR	53.09%
1Y total return	53.04%
20-day SMA	ARS 32,790.00
200-day SMA	ARS 30,602.80
3M price change	2.66%
3M total return	3.66%
3Y price change	118%
3Y return CAGR	33.18%
3Y total return	136.25%
50-day SMA	ARS 33,888.00
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 36,580.00
52-week high date	2026-09-07
52-week low	ARS 20,180.00
52-week low date	2025-10-27
5Y price change	767.41%
5Y return CAGR	57.19%
5Y total return	859.33%
6M price change	15.77%
6M total return	17.68%
All-time high	ARS 36,580.00
All-time high date	2026-09-07
All-time low	ARS 266.08
All-time low date	2017-06-13
Average true range (ATR)	ARS 984.55
Average volume	1.8K
Change from 52-week high	-7.27%
Change from 52-week low	68.09%
Change from all-time high	-7.27%
Change from all-time low	12,648%
Change from open	0%
Day's gap	-1.4%
Dollar volume	ARS 21M
High price	ARS 34,020.00
Low price	ARS 33,820.00
Monthly RSI	69.19
Open price	ARS 33,920.00
Position in 52-week range	50%
Previous close	ARS 34,400.00
Price vs 150-day SMA	8.86%
Price vs 20-day SMA	3.45%
Price vs 200-day SMA	10.84%
Price vs 50-day SMA	0.09%
Relative volume	0.34
RSI	54.33
Sharpe ratio	1.56
Sharpe ratio (3Y)	0.84
Sharpe ratio (5Y)	1.26
Sortino ratio	2.69
Sortino ratio (3Y)	1.38
Sortino ratio (5Y)	2.06
Volume	618
Weekly RSI	58.75
YTD price change	23.71%
YTD total return	27.42%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2B
Shares change (QoQ)	0.05%
Shares change (YoY)	0.47%
Shares held by insiders	0.05%
Shares held by institutions	83.01%
Short ratio	4.3 days

Deeper analysis on BCBA/BMY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/BMY report

Is a complete BCBA/BMY research report available?

No complete published report is available for bcba/BMY (BCBA/BMY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/BMY (BCBA/BMY)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/BMY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/BMY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/BMY

Frequently asked questions